PRUCALOPRIDE MEDSURGE prucalopride (as succinate) 1 mg tablet blister pack

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

prucalopride succinate, Quantity: 1.321 mg (Equivalent: prucalopride, Qty 1 mg)

Disponible des:

Medsurge Pharma Pty Ltd

formulario farmacéutico:

Tablet

Composición:

Excipient Ingredients: titanium dioxide; lactose monohydrate; macrogol 400; colloidal anhydrous silica; magnesium stearate; hypromellose; polysorbate 80; microcrystalline cellulose

Vía de administración:

Oral

Unidades en paquete:

28 tablets

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Prucalopride is indicated for the treatment of chronic functional constipation in adults in whom laxatives fail to provide adequate relief.,? Before Prucalopride is considered patients must have tried at least two different types of laxatives from different classes (at the highest tolerated recommended doses) for at least six months, but have not had adequate relief from constipation.,? If treatment with Prucalopride is not effective within four weeks, the benefit of continuing treatment should be reconsidered.

Resumen del producto:

Visual Identification: White to off-white, circular, film coated tablet with 'C' debossed on one side and '11' on the other side.; Container Type: Blister Pack; Container Material: PVC/PE/PCTFE (Aclar)/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Estat d'Autorització:

Registered

Data d'autorització:

2022-02-04